Jason Amello, Corporate Contrllr, Chief Accnt Officer at GENZYME CORP (GENZ), sold 533 shares at $45.62 ($24K) on 2010-05-25, disclosed to the SEC on 2010-05-26.
Open-market sale of $24k GENZ by Corporate Contrllr, Chief Accnt Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKBA | BUY | 2014-12-01 | $13K | — | Filing → |
| AKBA | BUY | 2014-03-27 | $68K | — | Filing → |
| GENZ | SELL | 2010-09-02 | $467K | — | Filing → |